Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Curr Opin Rheumatol. 2020 May;32(3):279–288. doi: 10.1097/BOR.0000000000000705

Table 3.

Selected studies associating silica inhalants with risk of rheumatoid arthritis.

Reference Study
design
Population
Sample (n)
RA outcomes (n)
Silica exposure methods RA outcome methods Cigarette
smoking and
other
adjustment
variables
Effect size
(95%
confidence
interval) for
silica and RA
risk
Comments
Klockars M, Br Med J (1987) [62] Retrospective cohort Central and south western Finland, male granite workers aged 15 to 72 years n=1,026 silica-exposed n=35 RA Dust concentration measured in workplace 1987 ACR criteria No smoking adjustment Age, residential area Incidence of disability pensions for RA: RR 5.08 (3.31-7.79)
  • Prevalence of RA and prevalence of patients receiving free medications for RA were significantly higher among granite workers than the general population

Turner S, Occup Environ Med (2000) [65] Case-control United Kingdom, pottery, sandstone, and refractory material (aluminosilicate or silica) workers n=290 n=58 RA Duration of physician-performed occupational history Physician-diagnosed RA Smoking status (ever or never) Age, sex, date, occupation, parity, pneumoconiosis Per 10 years silica exposure and all RA: OR 0.31 (0.16-0.61)
  • Only study suggesting a protective effect of silica for RA risk

  • Also investigated other cumulative silica exposures

Stolt P, Ann Rheum Dis (2005) [61] Case-control Sweden, men aged 18 to 70 years (EIRA Study) n=552 n=276 incident RA Self-reported exposure to stone dust, rock drilling, or stone crushing 1987 ACR criteria Smoking status (ever or never) Age, residential area All RA: OR 2.2 (1.2-3.9) RF-positive RA: OR 1.9 (0.9-4.0) RF-negative RA: OR 2.1 (0.8-5.1)
  • Older men were at particularly increased risk of all RA

Stolt, Ann Rheum Dis (2010) [60] Case-control Sweden, men aged 18-70 years (EIRA Study) n=1,236 n=577 incident RA Self-reported exposure to stone dust, rock drilling, or stone crushing 1987 ACR criteria No smoking adjustment Age, residential area All RA: OR 1.39 (0.98-1.96) ACPA-positive RA: OR 1.67 (1.13-2.48) ACPA-negative RA: OR 0.98 (0.57-1.66)
  • Rock drilling exposure showed particularly high risk of ACPA-positive RA

  • Analyses were also stratified by smoking and shared epitope status

  • Detected statistically significant silica-smoking interaction for ACPA-positive RA

Yahya A, Mod Rheumatol (2014) [59] Case-control Malaysia, males aged 18-70 years (MyEIRA Study) n=362 n=129 incident RA Self-reported exposure to stone dust, rock drilling, or stone crushing 1987 ACR criteria No smoking adjustment Age, sex, residential area All RA: OR 2.0 (0.9-4.6) ACPA-positive RA: OR 2.4 (1.0-5.6) ACPA-negative RA: OR 0.9 (0.2-4.5)
  • Also stratified by smoking status and investigated silica-smoking interaction

  • All subjects exposed to silica were also smokers

Blanc PD, Am J Med (2015) [57] Retrospective cohort Sweden, male construction workers aged 30 to 84 years n=240,983 n=713 incident RA Job-exposure matrices Billing code Smoking status (ever or never) Age All RA: RR 1.33 (1.11-1.60) Seropositive RA: RR 1.28 (1.02-1.61) Seronegative RA: RR 1.46 (1.03-2.07)
  • Also investigated other organic dusts and risk of autoimmune diseases

Vihlborg P, BMJ Open (2017) [58] Retrospective cohort Sweden, male iron foundry workers and general Swedish population n=2,187 n=18 seropositive RA Silica dust measurements for job categories (mg/m3) Billing code No smoking adjustment Age, sex, year Seropositive RA: SIR 1.70 (1.01-2.69)
  • Also investigated sarcoidosis

Ilar A, RMD Open (2019) [50] Case-control Sweden, EIRA Study and national registers n=126,534 n=11,285 RA Job-exposure matrices 2+ visits for RA and DMARD receipt Smoking pack-years (continuous) Age, sex, county, year, alcohol use All RA: OR 1.3 (1.2-1.5) Seropositive RA: OR 1.4 (1.2-1.5) Seronegative RA: OR 1.2 (1.0-1.4)
  • OR for seropositive RA higher with number of years exposed to silica

  • Results attenuated among women

Statistically significant results are bolded.

ACPA, anti-citrullinated protein antibody; ACR, American College of Rheumatology; DMARD, disease modifying anti-rheumatic drug; EIRA, Epidemiological Investigations of Rheumatoid Arthritis; OR, odds ratio; RA, rheumatoid arthritis; RF, rheumatoid factor; RR, relative risk; SIR, standardized incidence ratio.